Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | CES2 | O00748 | 2/20 | 0.39 |
| ▸ | CES1 | P23141 | 2/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | MPI | P34949 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | CA3 | P07451 | 1/20 | 0.33 |
| ▸ | CA6 | P23280 | 1/20 | 0.33 |
| ▸ | CA5A | P35218 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.33 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29533142 | 1.00 | ALDH1A1 (0.40) | ALDH1A1CYP3A4TDP1HPGDCES2 | |
| SCHEMBL7733603 | 0.91 | CYP3A4 (0.41) | ALDH1A1CYP3A4TDP1HPGDCES2 | |
| SCHEMBL8590726 | 0.88 | CYP3A4 (0.39) | ALDH1A1CYP3A4TDP1HPGDCES2 | |
| SCHEMBL546406 | 0.83 | CYP3A4 (0.39) | ALDH1A1CYP3A4TDP1HPGDCES2 | |
| SCHEMBL29574772 | 0.83 | CYP3A4 (0.39) | ALDH1A1CYP3A4TDP1HPGDCES2 | |
| SCHEMBL9630076 | 0.81 | CYP3A4 (0.55) | ALDH1A1CYP3A4TDP1HPGDTRPA1 | |
| SCHEMBL420514 | 0.79 | CYP3A4 (0.48) | ALDH1A1CYP3A4TDP1HPGDTRPA1 | |
| SCHEMBL1946132 | 0.79 | CYP3A4 (0.38) | ALDH1A1CYP3A4TDP1HPGDTRPA1 | |
| SCHEMBL20798330 | 0.79 | CYP3A4 (0.38) | ALDH1A1CYP3A4TDP1HPGDTRPA1 | |
| SCHEMBL1944267 | 0.79 | TDP1 (0.42) | ALDH1A1CYP3A4TDP1HPGDTRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1387 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12604597-B2 | Perovskite solar cell and manufacturing method | HUBEI WONDER SOLAR LIMITED LIABILITY COMPANY (CN) | 2026-04-14 | — | — | US | claimed |
| EP-4521905-A1 | PEROVSKITE SOLAR CELL AND MANUFACTURING METHOD | Hubei Wonder SOLAR Limited Liability Company (CN) | 2025-03-12 | — | — | EP | claimed |
| US-20240431125-A1 | PEROVSKITE SOLAR CELL AND MANUFACTURING METHOD | HUBEI WONDER SOLAR LIMITED LIABILITY COMPANY (CN) | 2024-12-26 | — | — | US | claimed |
| CN-118253468-A | Method for preparing coating, coating and device | 江苏菲沃泰纳米科技股份有限公司 | 2024-06-28 | — | — | CN | claimed |
| CN-117295372-A | Perovskite solar cell and preparation method thereof | 武汉万度光能研究院有限责任公司 | 2023-12-26 | — | — | CN | claimed |
| US-20230339973-A1 | RING-FUSED 2-PYRIDONE COMPOUNDS, METHODS FOR PREPARATION THEREOF AND THEIR USE IN THE TREATMENT AND/OR PREVENTION OF A DISEASE INVOLVING GRAM-POSITIVE BACTERIA | QURETECH BIO AB (SE) | 2023-10-26 | — | — | US | claimed |
| CN-116769094-A | Binuclear vanadium catalyst containing binghAC ligand, and preparation method and application thereof | 合肥工业大学 | 2023-09-19 | — | — | CN | claimed |
| CN-116525948-A | Method for inhibiting corrosion of aluminum foil of lithium battery current collector based on isocyanate additive | 临沂大学 | 2023-08-01 | — | — | CN | claimed |
| US-20230233536-A1 | RING-FUSED THIAZOLINO 2-PYRIDONES, METHODS FOR PREPARATION THEREOF AND THEIR USE IN THE TREATMENT AND/OR PREVENTION OF A DISEASE INVOLVING GRAM-POSITIVE BACTERIA | QURETECH BIO AB (SE) | 2023-07-27 | — | — | US | claimed |
| US-20230115208-A1 | RING-FUSED THIAZOLINO 2-PYRIDONES, METHODS FOR PREPARATION THEREOF AND THEIR USE IN THE TREATMENT AND/OR PREVENTION OF TUBERCULOSIS | QURETECH BIO AB (SE) | 2023-04-13 | — | — | US | claimed |
| EP-1377589-B1 | OXAZOLYL-PYRAZOLE DERIVATIVES AS KINASE INHIBITORS | PHARMACIA ITALIA SPA (IT) | 2005-09-07 | — | — | EP | claimed |
| EP-1003775-B1 | HEPATITIS C INHIBITOR PEPTIDES | BOEHRINGER INGELHEIM CA LTD (CA) | 2005-03-16 | — | — | EP | claimed |
| EP-1012180-B1 | HEPATITIS C INHIBITOR PEPTIDE ANALOGUES | BOEHRINGER INGELHEIM CA LTD (CA) | 2004-12-01 | — | — | EP | claimed |
| US-6143715-A | FOR TREATING AND PREVENTION OF HEPATITIS C VIURS INFECTIONS | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2000-11-07 | — | — | US | claimed |
| EP-1012180-A2 | HEPATITIS C INHIBITOR PEPTIDE ANALOGUES | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2000-06-28 | — | — | EP | claimed |
| EP-1003775-A2 | HEPATITIS C INHIBITOR PEPTIDES | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2000-05-31 | — | — | EP | claimed |
| WO-1999007733-A2 | HEPATITIS C INHIBITOR PEPTIDES | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 1999-02-18 | — | — | WO | claimed |
| WO-1999007734-A2 | HEPATITIS C INHIBITOR PEPTIDE ANALOGUES | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 1999-02-18 | — | — | WO | claimed |
| EP-0471236-B1 | Imidazopyridine derivatives and their use | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1995-03-15 | — | — | EP | claimed |
| EP-0054217-B1 | ANTHRAQUINONE DYES, PROCESS FOR THEIR PREPARATION, THEIR USE, AS WELL AS LIQUID-CRYSTAL MATERIAL CONTAINING ANTHRAQUINONE DYES | BAYER AG (DE) | 1984-06-27 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230115208-A1 | RING-FUSED THIAZOLINO 2-PYRIDONES, METHODS FOR PREPARATION THEREOF AND THEIR USE IN THE TREATMENT AND/OR PREVENTION OF TUBERCULOSIS | IL17A, TBCB, TBC1D15 | ALDH1A1 1018/4885CYP3A4 229/4885TDP1 3545/4885 |
| US-20230339973-A1 | RING-FUSED 2-PYRIDONE COMPOUNDS, METHODS FOR PREPARATION THEREOF AND THEIR USE IN THE TREATMENT AND/OR PREVENTION OF A DISEASE INVOLVING GRAM-POSITIVE BACTERIA | PGLS, BLVRB, SDHB | ALDH1A1 2766/4885CYP3A4 1963/4885TDP1 3402/4885 |
| US-12604597-B2 | Perovskite solar cell and manufacturing method | CDH1, SCNN1B, MSMO1 | ALDH1A1 4242/4885CYP3A4 422/4885TDP1 2429/4885 |
| US-20230233536-A1 | RING-FUSED THIAZOLINO 2-PYRIDONES, METHODS FOR PREPARATION THEREOF AND THEIR USE IN THE TREATMENT AND/OR PREVENTION OF A DISEASE INVOLVING GRAM-POSITIVE BACTERIA | NOD2, TLR4, TLR5 | ALDH1A1 2321/4885CYP3A4 2115/4885TDP1 2634/4885 |
| US-20240431125-A1 | PEROVSKITE SOLAR CELL AND MANUFACTURING METHOD | BRSK1, PRDM9, EYA3 | ALDH1A1 2150/4885CYP3A4 639/4885TDP1 2007/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.